News Focus
News Focus
Followers 79
Posts 1038
Boards Moderated 0
Alias Born 06/26/2014

Re: Biobillionair post# 163262

Tuesday, 11/27/2018 9:25:20 AM

Tuesday, November 27, 2018 9:25:20 AM

Post# of 448100
BB

In AMRN filing yesterday, the below quoted is there for everyone to read:

"Based on the positive REDUCE-IT results, we have begun promoting REDUCE-IT results to healthcare professionals in the United
States based on what we believe is our continuing obligation under our First Amendment settlement to ensure that our promotion of
Vascepa remains truthful and non-misleading
. We are also developing Vascepa for FDA approval of additional indications based on
REDUCE-IT."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News